Atul Dandekar's most recent trade in Maze Therapeutics Inc. was a trade of 7,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2026 | 7,500 | 29,143 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Sale of securities on an exchange or to another person at price $ 28.02 per share. | 29 Jun 2026 | 7,500 | 26,250 | - | 28.0 | 210,150 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.42 per share. | 29 Jun 2026 | 7,500 | 33,750 | - | 10.4 | 78,150 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2026 | 7,500 | 36,643 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Sale of securities on an exchange or to another person at price $ 26.34 per share. | 29 May 2026 | 7,500 | 24,808 | - | 26.3 | 197,554 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.42 per share. | 29 May 2026 | 7,500 | 32,308 | - | 10.4 | 78,150 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2026 | 8,320 | 20,204 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.42 per share. | 04 May 2026 | 8,320 | 18,823 | - | 10.4 | 86,694 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2026 | 5,985 | 27,725 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.42 per share. | 04 May 2026 | 5,985 | 24,808 | - | 10.4 | 62,364 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Sale of securities on an exchange or to another person at price $ 25.37 per share. | 29 Apr 2026 | 7,500 | 10,503 | - | 25.4 | 190,299 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2026 | 7,500 | 44,143 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.42 per share. | 29 Apr 2026 | 7,500 | 18,003 | - | 10.4 | 78,150 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2026 | 7,500 | 51,643 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.42 per share. | 30 Mar 2026 | 7,500 | 18,003 | - | 10.4 | 78,150 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Sale of securities on an exchange or to another person at price $ 29.26 per share. | 30 Mar 2026 | 6,710 | 11,293 | - | 29.3 | 196,305 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 30 Mar 2026 | 790 | 10,503 | - | 30.0 | 23,714 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 19,000 | 19,000 | - | - | Restricted Stock Units | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 7,500 | 59,143 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.42 per share. | 27 Feb 2026 | 7,500 | 18,003 | - | 10.4 | 78,150 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Sale of securities on an exchange or to another person at price $ 45.72 per share. | 27 Feb 2026 | 3,761 | 10,503 | - | 45.7 | 171,967 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Sale of securities on an exchange or to another person at price $ 45.13 per share. | 27 Feb 2026 | 3,739 | 14,264 | - | 45.1 | 168,756 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.42 per share. | 29 Jan 2026 | 7,500 | 18,003 | - | 10.4 | 78,150 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2026 | 7,500 | 66,643 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Sale of securities on an exchange or to another person at price $ 44.04 per share. | 29 Jan 2026 | 3,500 | 13,303 | - | 44.0 | 154,147 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Sale of securities on an exchange or to another person at price $ 45.01 per share. | 29 Jan 2026 | 2,800 | 10,503 | - | 45.0 | 126,022 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | Sale of securities on an exchange or to another person at price $ 43.18 per share. | 29 Jan 2026 | 1,200 | 16,803 | - | 43.2 | 51,821 | Common Stock |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | 29 Dec 2025 | 72,400 | 82,903 | - | 10.4 | 754,408 | Common Stock | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | 29 Dec 2025 | 72,400 | 74,243 | - | - | Stock Option (Right to Buy) | ||
| Maze Therapeutics Inc | Atul Dandekar | CSBO | 29 Dec 2025 | 66,365 | 16,538 | - | 40.5 | 2,688,552 | Common Stock | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | 29 Dec 2025 | 6,035 | 10,503 | - | 41.1 | 248,211 | Common Stock | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | 29 Dec 2025 | 100 | 10,603 | - | 10.4 | 1,042 | Common Stock | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | 29 Dec 2025 | 100 | 74,143 | - | - | Stock Option (Right to Buy) | ||
| Maze Therapeutics Inc | Atul Dandekar | CSBO | 29 Dec 2025 | 100 | 10,503 | - | 40.4 | 4,036 | Common Stock | |
| Maze Therapeutics Inc | Atul Dandekar | CSBO | 22 Sep 2025 | 25,000 | 25,000 | - | - | Restricted Stock Units |